Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HX15001 Injection in Moderate to Severe Active Ulcerative Colitis (Phase IIa)
CTR20260007Phase 2Active
- Sponsor
- Helixon
- Start
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of HX15001 in autoimmune colitis, sponsored by Helixon. Started Apr 2026; status: active.
02
Drugs
HX15001
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20260007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260007.